Kelsey KT - Search Results

1

Fas/APO-1 promoter polymorphism is not associated with non-melanoma skin cancer.

Nelson HH, Kelsey KT, Bronson MH, Mott LA, Karagas MR. Nelson HH, et al. Among authors: kelsey kt. Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):809-10. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11440968 No abstract available.

2

A prospective study of hprt mutant and mutation frequencies in treated cancer patients.

Caggana M, Liber HL, Coleman CN, Mauch P, Clark JR, Kelsey KT. Caggana M, et al. Among authors: kelsey kt. Cancer Epidemiol Biomarkers Prev. 1992 Nov-Dec;1(7):573-80. Cancer Epidemiol Biomarkers Prev. 1992. PMID: 1302570

3

Glutathione S-transferase mu genotype, diet, and smoking as determinants of sister chromatid exchange frequency in lymphocytes.

Cheng TJ, Christiani DC, Xu X, Wain JC, Wiencke JK, Kelsey KT. Cheng TJ, et al. Among authors: kelsey kt. Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):535-42. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7549811

4

Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure.

Wang X, Christiani DC, Wiencke JK, Fischbein M, Xu X, Cheng TJ, Mark E, Wain JC, Kelsey KT. Wang X, et al. Among authors: kelsey kt. Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):543-8. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7549812

5

Inherited glutathione-S-transferase deficiency is a risk factor for pulmonary asbestosis.

Smith CM, Kelsey KT, Wiencke JK, Leyden K, Levin S, Christiani DC. Smith CM, et al. Among authors: kelsey kt. Cancer Epidemiol Biomarkers Prev. 1994 Sep;3(6):471-7. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8000297

6

Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility.

Xu X, Kelsey KT, Wiencke JK, Wain JC, Christiani DC. Xu X, et al. Among authors: kelsey kt. Cancer Epidemiol Biomarkers Prev. 1996 Sep;5(9):687-92. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8877059

7

A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer.

Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, Willett WC, Hunter DJ. Chen J, et al. Cancer Res. 1996 Nov 1;56(21):4862-4. Cancer Res. 1996. PMID: 8895734

8

The glutathione S-transferase theta and mu deletion polymorphisms in asbestosis.

Kelsey KT, Nelson HH, Wiencke JK, Smith CM, Levin S. Kelsey KT, et al. Am J Ind Med. 1997 Mar;31(3):274-9. doi: 10.1002/(sici)1097-0274(199703)31:3<274::aid-ajim2>3.0.co;2-y. Am J Ind Med. 1997. PMID: 9055949

9

Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases.

Kelsey KT, Hankinson SE, Colditz GA, Springer K, Garcia-Closas M, Spiegelman D, Manson JE, Garland M, Stampfer MJ, Willett WC, Speizer FE, Hunter DJ. Kelsey KT, et al. Cancer Epidemiol Biomarkers Prev. 1997 Jul;6(7):511-5. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9232338

10

Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans.

Ishibe N, Wiencke JK, Zuo ZF, McMillan A, Spitz M, Kelsey KT. Ishibe N, et al. Among authors: kelsey kt. Cancer Epidemiol Biomarkers Prev. 1997 Dec;6(12):1075-80. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9419406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

501 results

Search Page

Filters